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Abstract
Sweeteners are substances with a sweet taste. Based on their relative sweetness compared to sucrose,
sweeteners are divided into intense or bulk sweeteners. In the past, the Scientific Committee on Food was the
scientific guarantor for the safety of food additives (including sweeteners) in use within the European Union
(EU). At present, this responsibility lies with the European Food Safety Authority. Extensive scientific
research has demonstrated the safety of all sweeteners permitted for food use in the EU. Their safety is
documented by the results of several in vitro and in vivo animal studies, tests in humans, and in some cases
epidemiological studies. Their safety has been evaluated through a risk assessment process covering hazard
identification, hazard characterization, exposure assessment and risk characterization. Permitted sweeteners
have been allocated an acceptable daily intake (ADI), which is the amount of a food additive, expressed as
mg/kg body weight, that can be ingested daily over a lifetime without incurring any appreciable health risk.
ADI ‘‘acceptable’’ means that the expected exposure to the substance used in foods at the levels necessary to
achieve desired technological effects does not represent a hazard to health. The consumption of sweeteners in
the quantities within the ADI does not constitute a health hazard to consumers.
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Introduction
H
ealth effects and safety aspects of food are
important issues for today’s consumers.
Although a general opinion is that con-
sumption of food products available on the market
does not constitute a risk for acute disease or any
adverse health effects later in life, some consumers
are concerned about the safety of certain food
additives. Sweeteners are among the food additives
that have created most debate. Sweeteners are
considered to be potential high-consumption food
additives because of their use in products consumed
in large amounts, such as soft drinks, and ‘‘table-
top’’ sweeteners. Although the scientific evidence
indicates that the sweeteners permitted for food use
are safe, some individuals and organizations remain
sceptical about long-term health risks due to their
consumption.
The aim of this paper is to describe briefly the
risk assessment of chemicals in foods, a scientific
process used for the safety assessment of sweeteners,
before their acceptance as food additives. It results
in an upper limit for the intake of the chemical, at
which or below which the intake is not expected to
be able to cause health-damaging effects. The
sweeteners permitted for food use in the European
Union (EU) are presented.
Definitions
Sweeteners are substances with a sweet taste.
Those used as alternatives to sucrose are often
called ‘‘alternative sweeteners’’, and are referred to
as ‘‘sweeteners’’ in this review.
Sweeteners differ in their sweetness potency.
Based on their relative sweetness compared to
sucrose they are divided into two classes (Table 1).
Sweeteners that, owing to their intense sweetness,
produce the required effect in minute quantities, are
called ‘‘intense’’ sweeteners. Some call them ‘‘artifi-
cial’’ sweeteners to stress that most of them are
produced by chemical synthesis, whereas sucrose
and other sugars naturally present in plants are
regarded as ‘‘natural’’. Intense sweeteners are
broadly used in beverages. In practice, none of the
intense sweeteners makes a significant contribution
to the energy value of the food in which they are
incorporated as the levels of use are low (1).
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The other class of sweeteners comprises sub-
stances with sweetness a little less than or compar-
able to that of sucrose. These sweeteners are called
‘‘bulk’’ sweeteners as they are fillers (compounds
providing or improving consistency). Bulk sweet-
eners are permitted for use as fillers and/or as
sweeteners in several food products, except for
soft drinks. As sweeteners they are permitted in,
for example, desserts, ice-cream, jam, preserves,
marmalade, sweets, baked goods, breakfast cereals,
mustard and sauces at the levels necessary to
achieve the desired effect (quantum satis). Permitted
bulk sweeteners are hydrogenated carbohydrates,
also referred to as sugar alcohols or polyols. Bulk
sweeteners are used commercially in food prepara-
tion because they offer certain functional advan-
tages over sucrose (e.g. lowering of the freezing
point of an ice-cream mix, reducing caramelization)
or certain dietetic advantages (e.g. in being more
slowly assimilated, being non-cariogenic or not
creating a demand for insulin). In contrast to
intense sweeteners, bulk sweeteners do not provide
an important reduction of energy content in food
products (1). Their energy value is approximately
10 kJ/g, while that of sucrose is 17 kJ/g.
Regulations for use and safety evaluation
The use of sweeteners in the EU is regulated by a
framework directive (2) and a specific directive (3).
The annexes to the specific directives provide the
information on which sweeteners are permitted in
different foodstuffs or groups of foodstuffs, together
with the maximum permitted doses. Permitted
sweeteners are listed in Table 1 and further pre-
sented below.
All sweeteners permitted for food use in the EU
have been subjected to a comprehensive examina-
tion for potential toxicological effects according
to the principles of toxicological testing of food
additives, before accepting their safety in use. Their
safety has been evaluated by the national autho-
rities, by the EU’s Scientific Committee on Food
(SCF) and by the Joint Food and Agriculture
Organization (FAO)/World Health Organization
(WHO) Expert Committee on Food Additives
(JECFA).
Table 1. E-numbera, relative sweetness (sucrose/1), acceptable daily intake (ADI), year of approval and last re-evaluation by the Scientific Committee on Food (SCF) of
sweeteners permitted in the European Union (EU)
E-number Sweetness compared
to sucrose
ADIb Year of
(mg/kg
body weight)
Approvalc Last evaluationc
Intense sweeteners
Acesulfame potassium E950 200 09 1984 2000
Aspartame E951 180 200 040 1984 2002
Cyclamate: cyclamic acid and its Na and Ca salts E952 30 07 1984 2000
Neohesperidin DC E959 1900 05 1988 1988
Saccharin and its Na, K and Ca salts E954 300 500 05 1977 1995
Sucralose E955 600 015 2000 2000
Thaumatin E957 20003000 Acc. 1984 1988
Bulk sweeteners
Erythritol E968 0.60.8 Acc.d 2003 2003
Isomalt E953 0.5 Acc.d 1984 1988
Lactitol E966 0.5 Acc.d 1984 1988
Maltitol and maltitol syrup E965 1 Acc.d 1984 1999
Mannitol E421 0.7 Acc.d 1984 1999
Sorbitol E420 0.51 Acc.d 1984 1984
Xylitol E967 1 Acc.d 1984 1984
aE-numbers are codes for food additives and are usually found on food labels throughout the EU.
bEstablished by the SCF.
cBy the SCF.
dProvided the laxative effect is borne in mind.
Na: sodium; Ca: calcium; K: potassium; Acc.: acceptable.
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The SCF was the scientific guarantor for the
safety of food additives in use within the EU from
1974 to March 2003. Since April 2003, this has
been the responsibility of the European Food
Safety Authority (EFSA) (http://efsa.europa.eu/).
Within EFSA, the Scientific Panel on Food Addi-
tives, Flavourings, Processing Aids and Materials in
Contact with Food (AFC Panel) is in charge of
sweeteners.
The first guidelines for the safety assessment of
food additives were issued by the SCF in 1980 (4).
In 2001 the SCF adopted its new guidelines (5).
JECFA started its work in 1956. This committee
offers in an informal manner the results of its
evaluations to the national governments of the
United Nations member states. JECFA issued
principles for safety assessment of food additives
in 1987 (6).
Both committees have evaluated some sweeteners
several times, when new data or new requests for re-
evaluation were acquired. The SCF’s opinions as
parts of several reports, as well as the JECFA
toxicological monographs for sweeteners and their
summary reports, are available on the internet
(79).
Database required for safety evaluation
A comprehensive database is required to conduct a
safety evaluation for regulatory purposes of any
substance as a food additive. It should include:
. results from studies on absorption, distribution
and metabolism in experimental animals and
humans
. in vitro and in vivo toxicological testing.
. administrative data
. technical data in relation to identity, purity,
stability and potential breakdown products
. manufacturing process
. technological need
. value to consumers
. proposed applications
. levels of use in different food categories
. estimated exposure resulting from the proposed
use.
Toxicological testing
The aim of toxicological testing is to determine
whether the substance, when used in the manner
and quantities proposed, would pose any appreci-
able risk to the health of the average consumer and
to those whose pattern of food consumption,
physiological or health status may make them
vulnerable, e.g. young age, pregnancy or diabetes
(5). The toxicological testing programme of food
additives includes core and supplementary studies.
The annex to guidance on submission for food
additive evaluations by the SCF provides considera-
tions underlying the core toxicological requirements
and discussions on the relevance, scope and use of
other studies (5).
Risk assessment and acceptable daily intake
The risk assessment of sweeteners is performed
following a general procedure for risk assess-
ment of chemicals in food, a scientific process that
requires expertise in toxicology and nutrition (for
the intake assessment) (Box 1). The procedure
consists of four steps: hazard identification, hazard
Box 1 . Risk assessment of food additives
The risk assessment of food additives contains four steps:
1) Hazard identification : identifies the adverse health
effects linked to the substance in question. For this
purpose scientific data from experiences from human
exposures, studies in experimental animals or in vitro
studies are needed.
2) Hazard characterization : leads to selection of the critical
data set in which the pivotal adverse effect is identified.
This data set is used to establish the doseresponse
effect for the substance. If the data demonstrate that the
substance is non-genotoxic the ‘‘no observed adverse
effect level’’ (NOAEL) is determined from the most
sensitive study in the most sensitive species tested. The
acceptable daily intake (ADI) is established from the
NOAEL by dividing it by a safety factor, which takes into
account species differences between humans and test
animals, and variation within humans (10, 11).
3) Exposure assessment : based on information regarding the
levels of a substance intended for use in different food
items and measurements of the intake of the relevant food
items in the country or region in question. The purpose is
to determine exposure to the substance (via intake of
food products) in the population as such and in special
population groups, and in individuals (maximum/minimum,
daily/over time). Information on food consumption may be
derived from food supply data, household surveys,
individual dietary surveys, total diet studies and/or
biomarkers. The figures are made available for the risk
characterization process.
4) Risk characterization : integrates information from ex-
posure assessment and hazard characterization into
advice suitable for use in decision making or risk manage-
ment. The conclusions may be that the expected/present
exposure is safe according to the established ADI or that
reductions in exposure are needed to comply with the
ADI.
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characterization, exposure assessment and risk
characterization (12). As the result of
hazard characterization an acceptable daily intake
(ADI) has been established for each sweetener. The
ADI is the amount of the food additive, expressed
as mg/kg body weight, that can be ingested daily
over a lifetime without incurring any appreciable
health risk. Intense sweeteners that are currently
permitted for food use in the EU have been
allocated a numerical ADI, with one exception
(Table 1). Bulk sweeteners that are currently per-
mitted for food use in the EU were found to be
‘‘acceptable’’ by the SCF. This indicates that the
expected exposure to the substance, arising from its
use or uses in food at the level necessary to achieve
the desired technological effect as known at the time
of evaluation, does not represent a hazard to health.
Re-evaluation of safety of sweeteners
There is at present no provision for periodic reviews
of the safety of permitted food additives. However,
the safety assessment of sweeteners (and other food
additives) is based on the knowledge and data
available at the time of assessment. When new
toxicity data become available in the scientific
literature, national experts and international expert
committees consider them with caution and may
undertake a re-evaluation of their safety. Depending
on the outcome, three scenarios are possible: the
ADI can be sustained or changed, or the use of a
sweetener as a food additive can be found to be
unacceptable.
The SCF published its first opinion on sweeteners
in 1985 (1). The first re-evaluation of the safety of
some of the sweeteners was conducted in 1989 (13).
Since then, the safety of some sweeteners has been
re-evaluated on several occasions.
Nordic experts discussed the safety aspects of
sweeteners in 1989 (14). In 1999 the Nordic Work-
ing Group on Food Toxicology and Risk Assess-
ment decided to examine whether the safety
evaluations, which formed the basis for conditions
of use, were still valid and adequate in the light
of standards for safety assessments at that time,
and whether significant new toxicological studies
had been published since previous evaluations. As a
result, a report covering all food additives permitted
in EU by April 2000 was submitted to the Nordic
Council of Ministers (15). This report contains
monographs of 12 sweeteners. The second part of
each monograph is an extract of the background
data as reported by the SCF and JECFA, supple-
mented by a short description of the core studies for
their assessment of the sweetener as well as relevant
studies on that compound published after the
evaluations by the SCF and JECFA.
Intake of sweeteners
Risk characterization requires comparison of
human intakes with the hazard characterization,
which in the case of sweetener is the relevant ADI.
Intakes may vary over time, owing to changing
patterns of use of sweeteners and food intake, and
therefore the risk characterization needs to be
undertaken at regular intervals, even though the
basic safety data and hazard characterization may
not have changed.
The specific directives have provisions for peri-
odic monitoring of the use of food additives. The
EU monitoring system is based on recommenda-
tions given in the report of the working group on
Development of methods for monitoring intake of
food additives in the EU, Task 4.2 of the Scientific
Co-operation on Questions Relating to Food (16).
The review of published data on intake of intense
sweeteners in the EU up to 1997 indicated that their
average intakes were below the relevant ADI values.
The intakes by the highest consumers of sweeteners
other than cyclamate were also below their ADIs.
The highest estimated intakes of cyclamate by
diabetic subjects and children were close to or
slightly above the ADI (17).
Studies on the intake of intense sweeteners in
different countries of the EU published since 1999
indicate that the average and 95th percentile intakes
of acesulfame potassium (acesulfame K), aspar-
tame, cyclamate and saccharin by adults are below
the relevant ADIs. Few data are available for
sucralose because of its recent introduction to the
market in the EU. Overall, there has not been a
significant change in the intakes of sweeteners in the
past 10 years. The only data indicating that the
intake of an intense sweetener could exceed its ADI
were the 95th percentile intakes of cyclamate in
children, particularly those with diabetes. However,
the recent studies have not generated reliable intake
data to address this possibility (18).
Thus, the available data indicate that the esti-
mated intakes of the intense sweeteners currently
permitted for the food use in the EU are below their
respective ADIs. Therefore, consumers need not
limit their intake of food products containing intense
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sweeteners for reasons pertaining to the sweeteners
themselves. However, some consumers interested
in maintaining healthy eating habits may limit the
intake of these products to avoid displacement of
more nutritious foods from the diet. This issue may
be of importance for some groups of the population,
e.g. children.
Bulk sweeteners permitted in the EU are not
included in the EU monitoring system. As no upper
limits of their use for sweetening purposes have been
specified, and as they are permitted for purposes
other than sweetening quantum satis in all foods
where additives may be used, except for beverages
other than liqueurs, an exposure estimate is not
possible.
Sweeteners permitted for food use in the
European Union
Nordic consumers can find a concise presenta-
tion of permitted sweeteners, including informa-
tion in which foodstuffs they are permitted, in the
‘‘E-number book’’, available in Danish and Swedish
(19). Each substance is presented in brief below. The
relative sweetness to sucrose, ADI, the year of
approval and, where applicable, the last re-evalua-
tion by the SCF are summarized in Table 1.
Intense sweeteners
The structural formulae of some intense sweeteners
is shown in Fig. 1 (20).
Acesulfame potassium (E950)
Acesulfame K is obtained by chemical synthesis and
purified through recrystallization. The compound is
freely soluble in water and very slightly soluble in
ethanol, and stable in the main temperature, pH
and time ranges. No by-products can be found in
beverages under normal usage and storage condi-
tions. Its stability and solubility in water facilitate
its use in foodstuffs (21). When acesulfame K is
used alone in quantities needed to achieve the
adequate sweetness it leaves an aftertaste. Therefore,
it is often used in sweetener blends, which produce a
more sugar-like taste. Acesulfame K is not metabo-
lized or stored in the body. After it is consumed, it is
quickly absorbed and then rapidly excreted un-
changed (22).
The SCF expressed its opinion on acesulfame K
for the first time in 1984 and established the ADI of
09 mg/kg body weight (1). Subsequently, the
Committee updated the safety of acesulfame K in
1991 (23) and in 2000 (24). On both occasions the
Committee was asked to consider whether the
2 year study in the rat (instead of the 2 year study
in the dog) could be considered as a basis for the
ADI. However, taking into account previously
available and new toxicokinetic data, the Commit-
tee considered that the dog remained an appropriate
species on which to base an ADI and maintained its
previous ADI. In 2000, the Committee also con-
sidered new mutagenicity studies and claims that
the old long-term studies indicated that acesulfame
K had a carcinogenic potential. The Committee
found that such claims could not be substantiated
Fig. 1. Structural formulae of intense sweeteners. Source: chemical information from the Environmental Health Information Program of the
National Library of Medicine (20).
Mortensen A
108
on the basis of the available data and maintained
the previous ADI.
Acesulfame K is permitted in a wide range of
food products and beverages. Among these are
table-top sweeteners, desserts, yoghurt, ice-cream,
baked goods, jam, preserves, marmalade, soft
drinks, sweets, mustard and sauces. The permit-
ted levels of use vary from 350 to 1000 mg/kg
depending on the food category. It takes about
0.5 kg marmalade containing 1000 mg/kg or 1.5 li-
tres of soft drink containing 350 mg/l acesulfame K
to achieve the ADI established by the SCF (19).
Aspartame (E951)
Aspartame consists of two amino acids, L-phenyla-
lanine and L-aspartic acid esterified to methyl
alcohol. It is unstable at prolonged high heat and
therefore it is not suitable for cooking or baking. It
is also unstable in aqueous solutions, where it is
gradually converted to diketopiperazine (DKP).
This results in loss of the sweet taste. Aspartame
has a sugar-like taste and enhances some flavours.
When combined with other intense sweeteners, e.g.
saccharin and/or cyclamate, the combinations taste
sweeter than expected from the sum of the indivi-
dual sweeteners.
When metabolized in the body, aspartame yields
about 50% phenylalanine, 40% aspartic acid and
10% methyl alcohol by weight (25). The body
utilizes the three components in the same way as
when they are derived from foods, such as milk,
fruit and vegetables. Further, the components of
aspartame are derived in much larger amounts from
these common foods than from beverages sweetened
with aspartame (26).
The SCF expressed its opinion on aspartame
and established an ADI of 040 mg/kg body weight
for the first time in 1984 (1). In 1988, the SCF
evaluated new data concerning the effects of aspar-
tame on blood and tissue levels of phenylalanine
and the possibility of behavioural and other neuro-
toxic effects due to consumption of aspartame. The
ADI was maintained (13). In 1997 the SCF
examined a report alleging a connection between
aspartame and increases in the incidence of brain
tumours in the USA (27, 28). In 2002, the SCF
carried out a further review of all the original and
more recent data on aspartame and concluded
that there was no need to revise the outcome of
the earlier risk assessment or the previously estab-
lished ADI (29). Recently, the EFSA’s AFC Panel
assessed a new long-term carcinogenicity study on
aspartame performed by the European Rammazzini
Foundation of Oncology and Environmental
Sciences (ERF) (30, 31) on the request of the
European Commission. The Panel concluded, on
the basis of all the evidence currently available from
the ERF study, other new data that had emerged
since 2002 on aspects other than carcinogenicity
and previous evaluations, that there was no reason
to revise the previously established ADI for aspar-
tame (32).
Aspartame is permitted in a wide range of food
products and beverages. Among these are table-
top sweeteners, desserts, yoghurt, ice-cream, baked
goods, jam, preserves, marmalade, soft drinks,
sweets, mustard and sauces. The permitted levels
of use vary from 350 to 2000 mg/kg depending on
food category. It takes about 1 kg of sweets contain-
ing 2000 mg/kg or 4 litres of soft drink containing
600 mg/l aspartame to achieve the ADI established
by the SCF (19).
Foods and beverages that contain aspartame
must carry a label statement indicating that the
product contains phenylalanine. This statement is
for the benefit of individuals with the hereditary
disease phenylketonuria, who must strictly limit
their intake of this amino acid. Normal, healthy
consumers do not need to restrict their phenylala-
nine intake.
Cyclamate (E952)
Three different compounds are referred to as
cyclamates: cyclamic acid, calcium cyclamate and
sodium cyclamate. Cyclamates, whether in the form
of sodium cyclamate or calcium cyclamate, are
stable in heat and cold and have good shelf-life.
The stability and solubility in water facilitate the use
of cyclamates in foodstuffs and beverages.
Cyclamate has the lowest sweetening power of
the intense sweeteners, but combined with other
intense sweeteners, a synergistic effect masks the
aftertaste associated with the use of a single sweet-
ener. The mixture of 10 parts cyclamate and one
part of saccharin was widely used in foods and
beverages during the 1960s. In 1969, however,
cyclamate was prohibited in many countries be-
cause bladder tumours were found in rats fed with
the 10:1 cyclamatesaccharin mixture (33). Since
then, several additional toxicity and carcinogenicity
studies have been conducted with cyclamate, the
cyclamatesaccharin mixture and cyclamate meta-
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bolite cyclohexylamine (CHA). These studies were
considered negative with regard to a carcinogenic
effect of both cyclamate and CHA (34).
Most people do not metabolize cyclamate. The
absorbed compound is excreted unchanged in the
urine. Unabsorbed cyclamate can be metabolized by
human microflora of the lower gut to CHA (35).
There are large interindividual variations in conver-
sion rates. Some peoples are recognized as non-
converters and some as high converters. CHA
causes testicular atrophy in rats (34).
The SCF expressed its opinion on cyclamate,
CHA and another metabolite, dicyclohexylamine,
in 1984, and established a temporary ADI of
011 mg/kg body weight expressed as cyclamic
acid, for cyclamic acid, and its calcium and sodium
salts (1). The ADI was temporary because of
uncertainties relating to the relevance for man of
the testicular damage found in rats with CHA.
Thereafter, the Committee reviewed cyclamate on
several occasions, when additional data became
available (13, 23, 28). Each time the temporary
ADI of 011 mg/kg was maintained. Finally in
2000, the SCF established a full ADI of 07 mg/kg
body weight, expressed as cyclamic acid, for cycla-
mic acid and its calcium and sodium salts (36).
Cyclamate is permitted in a range of food
products, e.g. in water-based flavoured drinks, and
in milk- and milk derivative-based or fruit juice-
based drinks. The permitted levels of use vary from
250 to 1500 mg/kg depending on food category. It
takes about 1.5 litres of soft drink containing
250 mg/l cyclamates to achieve the ADI established
by the SCF.
Neohesperidin dihydrochalcone (E959)
Neohesperidin dihydrochalcone (DH) is a flavone
glucoside prepared from naringin by various che-
mical processes (1). Neohesperidin DH is not
present in nature, but structurally related flavonoids
and their corresponding dihydrochalcones occur
naturally in many plants, e.g. citrus fruits. The
sugar component of neohesperidin DH is a dis-
accharide b-neohesperidose. Neohesperidin DH is
freely soluble in hot water and very slightly soluble
in cold water. The sweetener can be used in
combination with other sweeteners for its sweeten-
ing and flavouring properties.
Ingested neohesperidin DH is not absorbed to a
significant extent. It is metabolized by gut flora,
yielding the same or similar breakdown products as
its naturally occurring analogues.
The SCF expressed its opinion on neohesperidin
DH for the first time in 1984. The Committee
concluded that the compound was not toxicologi-
cally acceptable owing to a lack of data (1). In 1988,
the SCF established an ADI for neohesperidin DH
of 05 mg/kg body weight (13).
Neohesperidin DH is permitted in a range of
food products and beverages. Among these are
desserts, yoghurt, ice-cream, baked goods, jam,
preserves, marmalade, soft drinks, sweets, mustard
and sauces. The permitted levels of use vary from
50 to 150 mg/kg depending on the food category. It
takes about 2 kg of sweets containing 150 mg/kg or
10 litres of soft drink containing 350 mg/l neohe-
speridin DH to achieve the ADI established by the
SCF (19).
Saccharin (E954)
E954 covers saccharin, sodium saccharin, calcium
saccharin and potassium saccharin. Saccharin is
obtained by chemical synthesis. It is slightly soluble
in water, soluble in alcaline and sparingly soluble in
ethanol. Saccharin has a stable shelf-life. Its use in
foods dates back to 1907. This sweetener leaves a
bitter/metallic aftertaste. Therefore, it is often used
in sweetener blends, which produce a more sugar-
like taste.
Saccharin does not undergo detectable metabo-
lism in either humans or other animals (22). There
has been some controversy over the safety of
saccharin in the past. Some feeding studies indi-
cated that saccharin at high dosage produced
tumours in the bladder of the male rat (37). Since
then, several animal studies have provided informa-
tion on the mechanisms behind this carcinogenic
response in male rats, as well as demonstrating no
carcinogenic effect of saccharin in other species.
Furthermore, extensive research on human popula-
tions has established no association between sac-
charin and cancer.
Saccharin and its sodium, potassium and calcium
salts were first evaluated by the SCF in 1977, when a
temporary ADI of 02.5 mg/kg body weight was
allocated (37). The SCF reviewed saccharin again in
1984 and decided to maintain the temporary ADI
set in 1977 until the questions concerning mechan-
ism and relevance of male rat bladder tumours could
be clarified by new data (1). Following submission of
new data and an industry request for re-evaluation
Mortensen A
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of the temporary ADI, the SCF reconsidered
saccharin in 1990 (38). The temporary ADI was
not changed. In 1995, the SCF established a full ADI
for sodium saccharin of 05 mg/kg body weight
(which is 03.8 mg/kg body weight when ADI is
expressed as the free acid) (39). At that time, the
SCF considered both previous and new experimen-
tal information available and the extensive epide-
miological data with no evidence of any relationship
between saccharin intake and bladder cancer in
humans.
Saccharin is permitted in a wide range of food
products and beverages, including table-top sweet-
eners, desserts, yoghurt, ice-cream, baked goods,
jam, preserves, marmalade, soft drinks, sweets,
mustard and sauces. The permitted levels of use
vary from 100 to 500 mg/kg depending on the food
category. It takes about 0.5 kg of sweets containing
500 mg/kg or 3.5 litres of soft drink containing
500 mg/l saccharin to achieve the ADI established
by the SCF (19).
Sucralose (E955)
Sucralose is also known as 4,1?,6?-trichlorosucrose
(TGS) or trichlorosucrose. Sucralose is derived from
sucrose by the selective replacement of three hy-
droxyl groups by chlorine atoms.
Sucralose is readily soluble in water, lower
alcohols and other polar solvents, giving solutions
of neutral pH. In acid solutions, e.g. in some soft
drinks, sucralose hydrolyses slowly to its consti-
tuent monosaccharides, 4-chloro-4-deoxygalactose
(4-CG) and 1,6-dichloro-1,6-dideoxyfructose (1,6-
DCF).
Sucralose is not metabolized or stored in the
body. After it is consumed, it is quickly absorbed
and then rapidly excreted unchanged.
The SCF expressed its first opinion on sucralose
in 1989 (13). At that time the SCF considered
sucralose to be toxicologically unacceptable as
several outstanding questions emerged from the
evaluation of the available data. In 2000, the SCF
considered further studies and established the ADI
of 015 mg/kg body weight (40).
Sucralose is permitted in a wide range of food
products and beverages. Among these are soft
drinks, desserts, ice-cream, confectionery, preserves
and sandwich spreads. The permitted levels of use
vary from 10 mg/l to 1000 mg/kg depending on the
food category. It takes about 2 kg of a dessert
containing 400 mg/kg or 3 litres of soft drink
containing 300 mg/l sucralose to achieve the ADI
established by the SCF.
Thaumatin (E957)
Thaumatin is a protein sweetener of plant origin. It
consists essentially of two proteins, thaumatin I
and II, together with minor amounts of other plant
constituents derived from the source material.
Thaumatin is obtained by aqueous extraction
from the arils of the fruit of the plant Thaumato-
coccus daniellii (Benth.). It is very soluble in water,
and metabolized as other proteins.
The SCF expressed its opinion on thaumatin for
the first time in 1984, found the sweetener tempora-
rily acceptable, and requested additional data on
possible receptor binding and endocrine activity (1).
After considering the additional data, the SCF
found the sweetener acceptable (13).
Thaumatin is permitted as a sweetener in ice-
cream and sweets at levels up to 50 mg/kg and as a
taste enhancer in soft drinks, desserts and diary
products at levels up to 0.5 mg/l and 5 mg/kg,
respectively.
Bulk sweeteners: polyols
Polyol bulk sweeteners have a laxative effect in
humans and animals when consumed in excessive
doses, owing to the osmotic effects of unabsorbed
polyols reaching the colon. Polyols differ in their
potency to cause laxation. Consumption in the
order of 20 g per person per day of polyols is
unlikely to cause undesirable laxative symptoms
(1, 13).
The SCF expressed its opinion on most polyols
in 1984 (1). Its opinion on erythritol was ex-
pressed in 2003 (41). In accepting the continued
use of polyols, the SCF emphasized that this
should not be interpreted as meaning the accep-
tance of unlimited use in all foods at any
technological level, but that the laxative effect
should be borne in mind (1).
Erythritol (E968)
Erythritol occurs naturally in minor amounts in
some fruits (watermelons, pears and grapes), mush-
rooms, and fermented foods such as soya sauce, beer,
sake, wine and cheese. Erythritol is manufactured
from wheat or cornstarch by enzymic hydrolysis
yielding glucose, which is fermented by yeast-like
fungi. It is very soluble in water and slightly soluble
in ethanol.
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In animals and humans, depending on dose,
6090% of ingested erythritol is rapidly absorbed
from the small intestine and excreted unchanged
in the urine. Unabsorbed erythritol undergoes
microbial fermentation in the large bowel to
volatile short-chain fatty acids or is excreted
with faeces.
Human studies indicate no significant effects on
carbohydrate metabolism. Erythritol causes a laxa-
tive effect in higher doses than other polyols.
Isomalt (E953)
Isomalt (synonyms hydrogenated isomaltulose and
palatinit) is an equimolar mixture of glucose-sorbi-
tol and glucose-mannitol. The product also contains
minor amounts of D-mannitol and D-sorbitol. It can
be produced by catalytic hydrogenation of isomal-
tulose prepared by enzymic isomerization of sucrose.
Isomalt is soluble in water and very slightly soluble
in ethanol.
After ingestion, isomalt is incompletely hydro-
lysed in the small intestine to glucose, sorbitol and
mannitol, and subjected to microbial fermentation
in the large gut.
Human tolerance studies indicate that ingestion
of 1020 g per day does not have a laxative effect (1)
and that after a few days of adaptation 50 g per day
of isomalt could be tolerated (13).
In 1988 the SCF considered a new submission of
data on the laxative effect of isomalt, but main-
tained the original evaluation from 1984 (13).
Lactitol (E966)
Lactitol, also called lactositol, lactit and lactobiosit,
consists of galactose and glucitol. It is obtained by
catalytic hydrogenation of lactose. The product may
contain minor amounts of other polyols. It is very
soluble in water.
Human studies indicate that lactitol is not
hydrolysed in the small intestine, but is ferm-
ented by the microflora of the large intestine (13).
At an intake of about 50 g per day diarrhoea may
occur.
In 1988 SCF considered the new data on meta-
bolism and gastric effects, but maintained its
previous evaluation from 1984 (13).
Maltitol (E965)
Maltitol and maltitol syrup are also known as D-
maltitol and hydrogenated maltose or hydrogenated
high-maltoseglucose syrup, hydrogenated glucose
syrup (HGS) and lycasin, respectively. Maltitol may
contain very small amounts of other polyols, while
maltitol syrup contains significant amounts of
other polyols, ranging from sorbitol to hydroge-
nated polysaccharides containing more than three
glucitol units. Maltitol and maltitol syrup are very
soluble in water.
Maltitol and maltitol syrup are manufactured by
catalytic hydrogenation of high-maltoseglucose
syrup. Maltitol is isolated by crystallization.
After ingestion, maltitol/maltitol syrup is meta-
bolized into glucose and sorbitol, particularly by
the intestinal flora. Human tolerance studies
showed a laxative effect at intake levels of 3050 g
per day (1).
In 1999 the SCF evaluated maltitol syrup with
a new specification and found its continued use
acceptable (42). Recently, the AFC Panel expressed
its opinion on a new production method for
maltitol (43).
Mannitol (E421)
Mannitol, also known as mannite, is very soluble
in water and slightly soluble in ethanol. It is
manufactured either by catalytic hydrogenation of
glucose and fructose made from invert sugar or
starch or by discontinuous fermentation under
aerobic conditions by a conventional strain of
yeast.
After ingestion mannitol is poorly absorbed and
laxative effects have been reported with doses as low
as 1020 g per day (1).
Sorbitol (E420)
Sorbitol is obtained by catalytic hydrogenation
of glucose. Sorbitol syrup is a mixture of polyols,
consisting predominantly of D-sorbitol and vari-
able amounts of D-mannitol and hydrogenated
oligosaccharides. It is obtained by catalytic hydro-
genation of glucose syrup. Sorbitol and sorbitol
syrup are very soluble in water and slightly
soluble in ethanol. Laxative effects in human
tolerance studies were noted at intake levels above
50 g per day (1).
Xylitol (E967)
Xylitol is called wood sugar or birch sugar as it can
be extracted from birch, raspberries, plums and
corn. Xylitol is manufactured by catalytic hydro-
genation of xylan, obtained from xylan-rich plant
material by acid hydrolysis. The product contains
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minor amounts of other polyols. It is very soluble in
water and sparingly soluble in ethanol.
Human tolerance studies indicate that consump-
tion exceeding 50 g per day leads to diarrhoea (1).
Other sweet substances approved as novel
foods or novel food ingredients
Apart from the approved sweeteners mentioned
above, two other sweet substances deserve attention.
These are tagatose and trehalose, compounds that
are similar in function to the polyols, although they
are actually sugars rather then sugar alcohols.
Tagatose
Tagatose is made from lactose and has a structure
similar to that of fructose (44). It is almost as sweet
as sucrose and has flavour-enhancing properties.
The metabolism of tagatose is similar to that of
fructose, but the compound is incompletely ab-
sorbed in the small intestine and therefore provides
few calories and has a minimal effect on blood
glucose and insulin levels. The major part of the
ingested tagatose is fermented by the colon micro-
flora, resulting in the production of short-chain
fatty acids, which are then absorbed almost com-
pletely and metabolized.
Since tagatose is absorbed slowly and incomple-
tely, the consumption of excessive amounts may
produce the same intestinal side-effects as polyols
(flatulence, laxation).
Owing to its physical properties tagatose can be
applied in a wide range of foods and beverages.
Tagatose is approved as a novel food ingredient in
the EU (45) and can be used in several foods, e.g.
beverages, cereals, confectionery and diary pro-
ducts.
Trehalose
Trehalose is a disaccharide composed of two
glucose molecules bound by an a-1,1- linkage (46).
It is extensively but not abundantly found in the
nature. The commercial product is made from
starch by an enzymic process. Its relative sweetness
is 45% of sucrose. Trehalose has high thermostabil-
ity and a wide pH stability range.
The metabolism of trehalose is similar to that of
other disaccharides. Ingested trehalose is hydrolysed
to glucose and absorbed in the small intestine.
Trehalose is accepted as a novel food or novel
food ingredient in the EU (47). However, commer-
cial applications seem limited so far.
Sweeteners not currently permitted in the
European Union
Alitame
Alitame is an intense sweetener developed in the
early 1980s. It is 2000 times sweeter than sucrose.
Alitame is made from the amino acids L-aspartic
acid and D-alanine, and a novel amine. The aspartic
acid component is metabolized in the same way as
from other sources. The alanine passes through the
body with minimal metabolic changes.
Alitame has a clean, sweet taste. The compound
offers good stability at elevated temperatures and
over a broad pH range. It is highly soluble in water.
When combined with other intense sweeteners, it
has a synergistic sweetening effect. Alitame has the
potential to be used in a wide range of food
products and beverages. Among these are table-
top sweeteners, soft drinks, milk products, desserts,
fruit preparations, baked goods, chewing gum and
sweets.
Alitame has been evaluated by the JECFA. The
Committee allocated an ADI of 01 mg/kg body
weight (48). The sweetener is currently marketed
under the brand name Aclame in Mexico, Australia,
New Zealand and China.
Neotame
Neotame is a dipeptide methyl ester derivative that
is chemically related to aspartame. Neotame has a
sweetness factor that is approximately 700013,000
times greater than that of sucrose and approxi-
mately 3060 times greater than that of aspartame,
depending on the food application.
Neotame has a clean, sweet taste like sucrose, and
flavour-enhancing properties. It is moderately heat
stable. Neotame has the potential to be used in all
areas where sweeteners are currently used, e.g. table-
top sweeteners, beverages, milk products, desserts,
fruit preparations, baked goods, chewing gum and
sweets.
Neotame is rapidly metabolized and completely
eliminated, and does not accumulate in the body.
The major metabolic pathway is hydrolysis of the
methyl ester, which yields de-esterified neotame and
methanol in equimolar amounts. Because only very
small amounts of neotame are needed to sweeten
foods, the intake of methanol that may result from
ingestion of neotame-containing foods and bev-
erages is considered negligible compared with that
from other dietary sources. Neotame is not directly
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metabolized to phenylalanine and the availability of
this amino acid from neotame is negligible. The
increment in phenylalanine exposure from neotame
ingestion is therefore not considered to be of health
significance for people suffering from phenylketo-
nuria. Neotame is under current review by EFSA.
Neotame was evaluated by the JECFA and assigned
an ADI of 02 mg/kg body weight (49).
Neotame has been approved for use as a food
additive in a number of countries, including the
USA, Australia, New Zealand, Mexico, Romania,
Costa Rica, China, Guatemala, Russia and the
Philippines.
Stevioside
Stevioside is a glucoside of the diterpene derivative
steviol, extracted from the leaves of the stevia plant
(Stevia rebaudiana Bertoni). It is an intense sweet-
ener, 200300 times sweeter than sucrose. Both the
plant and extracts of the plant have a long tradition
of use in South America. Stevia has been used for
several years in Japan.
The SCF considered stevioside for the first time
during its comprehensive review of sweeteners in
1984 and found the compound to be unacceptable
as a sweetener (1). The review on the safety of
stevioside was updated by the SCF in 1989 (13)
and in 1999, following a submission of additional
information. The data considered by the SCF
indicated that the extract has the potential to
produce adverse effects in the male reproductive
system that could affect fertility, and that a meta-
bolite produced by the human gut microflora,
steviol, is genotoxic. The SCF reiterated its earlier
opinion that the substance was not acceptable as a
sweetener based on the available data (50).
In 1998 the SCF was asked to assess the safety
of leaves of S. rebaudiana Bertoni as a novel food.
The SCF concluded that the information submitted
on the plant products was insufficient with regard to
specification and standardization of the commercial
product and contained no safety studies (51).
Concluding remarks
Concurrently with developments in the food market
providing consumers with a variety of sugar-free
products containing sweeteners, consumers have
grown more aware about food safety issues and
want more information about the safety of com-
pounds added to foods. Thus, the risk assessment
process in the EU is challenged by demands for
greater transparency. The EFSA website (http://
efsa.europa.eu) is an example of the implication of
the transparency principle in the risk assessment of
chemicals in European foods.
All sweeteners permitted for use in food in the
EU have been subjected to a thorough safety
evaluation before their acceptance. Their safety
has been documented by the results of many in
vitro and in vivo animal studies, tests in humans
and, in some cases, epidemiological studies. There-
fore, consumption of sweeteners in the quantities
within the ADI does not constitute a health hazard
to consumers.
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